Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Novartis

Novartis

Rank: 5

2021 Rank: 3

Basel, Switzerland
www.novartis.com

2021 Revenues ($USD) : $51,626,000,000
2021 R&D spend : $9,540,000,000
2021 Number of Employees : 104,323
Fiscal Year End : 12/31/2021
Leader : CEO Vas Narasimhan

The Basel, Switzerland–headquartered company anticipates sales growth of at least 4% CAGR from 2020 to 2026. In 2021, the drug Cosentyx had $4.7 billion in sales and 17% sales growth. Novartis noted that the drug Entresto (sacubitril/valsartan), a combination medication used for heart failure, grew 40% in FY2021. Entresto sales were $3.5 billion. Other leading drivers of growth include Cosentyx (secukinumab), Kesimpta (ofatumumab), Kisqali (ribociclib) and Zolgensma (onasemnogene abeparvovec-xioi). Novartis is reportedly considering selling its Sandoz subsidiary, which is one of the largest generic drug companies. In 2021, the unit drove $9.6 billion in sales. In March, Sandoz acquired the UK-based medical and drug delivery device development firm Coalesce Product Development. —BB

Novartis

[View of Fabrikstrasse 15, Novartis Campus Basel. Image courtesy of Novartis.]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE